Company Information
- Type:
- Company
- Country:
- Colombia
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 12 August 2014 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 30-Jul-2024 | 2024 Communication on Progress | Submitted |
| 27-Nov-2023 | 2023 Communication on Progress | Submitted |
| 20-Nov-2022 | Tu Tranquilidad es nuestra razón de servir | Active |
| 26-Nov-2021 | Bienestar en tiempos de pandemia | Active |
| 28-Nov-2020 | Acompañamos a las personas en el camino hacia su bienestar | Active |
| 28-Nov-2019 | Entregamos esperanza de vida | Active |
| 30-Aug-2019 | Grace Letter | Not applicable |
| 30-Aug-2018 | AUDIFARMA Esperanza de Vida | Active |
| 31-May-2018 | Grace Letter | Not applicable |
| 01-Jun-2017 | Communication on Progress Audifarma S.A. Su necesidad, Nuestra Prioridad | Active |
| 03-Mar-2017 | Grace Letter | Not applicable |
| 27-Oct-2016 | Reporting Cycle Adjustment | Not applicable |
| 10-Nov-2015 | Communication on Progress | Active |
| 11-Aug-2015 | Grace Letter | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.